General Information
With New Validation Data, BillionToOne Boosts Commercial Prospects of Therapy Selection Assay
Read
News & Media
Media Coverage
ASCO24: BillionToOne unveils results from tumour profiling test comparison
Read
Media Coverage
GenomeWeb- BillionToOne Pushing Forward in Cancer Diagnostics With First Data on Response Monitoring Test
Read
Media Coverage
BioWorld MedTech Interview- BillionToOne test reduces need for Rhogam in 40% of Rh-negative pregnancies
Read
Press Releases
BILLIONTOONE MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TEST
Read
Media Coverage
BillionToOne is recognized by Forbes as one of America’s Best Startup Employers for 2024!
Read
